Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008

Abstract

DiabCare Bangladesh 2008 evaluated the current status of diabetes care in Bangladesh as a continuation of similar cross-sectional study conducted previously in 1998. The current study recruited 1952 patients from general hospitals, diabetes clinics and referral clinics to study current scenario of diabetes management from 01 March 2009 to 31 March 2009. We report the results of type 2 diabetic population who constituted 95.3% (n=1860). Results showed deteriorating glycaemic control with mean HbA1c of 8.6±2.0% with only 23.1% of the patients achieving American Diabetes Association (ADA) target of <7%. 896 (47.0%) patients were hypertensive and 850 (94.9%) were on antihypertensive medication. 70.8% of patients had LDL levels >2.6 mmol/L; 43.8% had triglycerides >2.2 mmol/L; 44.1% had HDL<1 mmol/L despite 48% of the patients being on lipid lowering agents. Microvascular, macrovascular and severe late complications were reported in 39.2%, 9.9% and 12.1% patients respectively. The rates of diabetic complications were cataract 12.9%, microalbuminuria 15.7%, neuropathy symptoms 31.7%, leg amputation 1.2% and history of angina pectoris was 6.6%. Quality of life evaluation showed that about half of patients have poor quality of life. Also, there was poor adherence to diet, exercise and self testing of blood glucose. In conclusion, majority of the patients were still not satisfactorily controlled. There is an urgent need for effective remedial measures to increase adherence to practice guidelines and to educate both patients and healthcare personnel on importance of achieving clinical targets for metabolic control.

A Cross-sectional Study to Evaluate Diabetes Management, Control and Complications in Patients with type 2 Diabetes in Bangladesh

“…It has enrolled relatively higher patients (2092) as compared to previous DiabCare studies. 10, The mean age of the patients (51.3 years) is consistent with previous DiabCare and other studies conducted in Bangladesh. 10,16 The patients in this study had relatively shorter disease duration (6 years) as compared to DiabCare 2008 (7.9 years).…”

“…10, The mean age of the patients (51.3 years) is consistent with previous DiabCare and other studies conducted in Bangladesh. 10,16 The patients in this study had relatively shorter disease duration (6 years) as compared to DiabCare 2008 (7.9 years). Greater proportion of patients with family history of diabetes (61.5% vs. 52.8%) and smoking habits (11.3% vs. 8.2%) has been observed as compared to DiabCare 2008 study.…”

“…9 (9) DiabCare Bangladesh 1998 and 2008 have informed healthcare policy and influenced diabetes management programmes in the country. 10,11 Consistent with previous studies, DiabCare Bangladesh 2012 was performed to describe diabetes management, control and complications. It also evaluated the associated primary and secondary preventive efforts and treatment adherence in patients with T2DM living in Bangladesh.…”

Frequency and Risk Factors of Diabetic Complications among Selected Group of Diabetic Patients: Real-life Scenario from a Developing Country, Bangladesh

“…10 Here we found that, nephropathy was present in 42.5% of study subjects then retinopathy in 37.8%, neuropathy in 29.8%, CAD in 25.8%, PVD in 14% and stroke in 11%. But previous study from Bangladesh showed microvascular, macrovascular and severe late complications in 39.2%, 9.9% and 12.1% of patients respectively.…”

“…But previous study from Bangladesh showed microvascular, macrovascular and severe late complications in 39.2%, 9.9% and 12.1% of patients respectively. 10 It was seen from our study that microvascular complications were common among the study subject who had long duration of diabetes, hypertension, obesity and macrovascular complications were common among the patients with male sex, poor glycemic status, dyslipidemia and family history of DM. There are several study from India, 11 one showed neuropathy was more common (37%) when compared with retinopathy (17%) and nephropathy (20%).…”